PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 82 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $15,540 | -42.4% | 15,922 | -32.8% | 0.00% | – |
Q3 2022 | $27,000 | -79.5% | 23,700 | -66.7% | 0.00% | – |
Q2 2022 | $132,000 | -89.8% | 71,116 | -83.4% | 0.00% | – |
Q1 2022 | $1,295,000 | -60.4% | 427,334 | -50.6% | 0.00% | – |
Q4 2021 | $3,272,000 | -12.7% | 865,588 | +19.4% | 0.00% | – |
Q3 2021 | $3,748,000 | +110.2% | 724,901 | +55.7% | 0.00% | – |
Q2 2021 | $1,783,000 | +675.2% | 465,520 | +405.5% | 0.00% | – |
Q4 2020 | $230,000 | +70.4% | 92,084 | +40.8% | 0.00% | – |
Q3 2020 | $135,000 | +321.9% | 65,390 | +540.6% | 0.00% | – |
Q2 2020 | $32,000 | -42.9% | 10,208 | -58.7% | 0.00% | – |
Q1 2020 | $56,000 | -24.3% | 24,704 | +20.1% | 0.00% | – |
Q4 2019 | $74,000 | -90.7% | 20,563 | -91.2% | 0.00% | – |
Q3 2019 | $796,000 | +30.3% | 233,417 | +79.4% | 0.00% | – |
Q2 2019 | $611,000 | +157.8% | 130,092 | +46.4% | 0.00% | – |
Q4 2018 | $237,000 | -69.6% | 88,846 | -36.2% | 0.00% | – |
Q3 2018 | $779,000 | -20.2% | 139,259 | -27.7% | 0.00% | – |
Q2 2018 | $976,000 | -49.1% | 192,503 | -31.6% | 0.00% | – |
Q1 2018 | $1,919,000 | +362.4% | 281,232 | +411.3% | 0.00% | – |
Q4 2017 | $415,000 | +336.8% | 55,003 | +233.4% | 0.00% | – |
Q3 2017 | $95,000 | -73.3% | 16,500 | -87.2% | 0.00% | – |
Q2 2015 | $356,000 | – | 129,390 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
Annandale Capital, LLC | 67,000 | $70 | 0.02% |
WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
Sigma Planning Corp | 343,934 | $357,691 | 0.01% |